US Patent Number
The presently-disclosed subject matter includes light-activated ruthenium compounds. In some embodiments the compounds release one or more ligands when exposed to light, and in specific embodiments the light includes a wavelength of about 500 nm to about 1000 nm. The present compounds can also comprise an overall charge, wherein the overall charge can be a positive overall charge or a negative overall charge. Further still, embodiments include methods of treating cancer in a subject by administering a compound and then exposing a site of the subject to light.
University of Kentucky Research Foundation, Lexington, KY (US)
Glazer, Edith C. and Heidary, David K., "Light-Activated Compounds" (2016). Chemistry Faculty Patents. 35.